In a murine model of CHIP (JAK2V617F mutation, commonly found in elderly individuals with CHIP), AIM2 activation in myeloid cells was shown to drive excessive IL-1β release, macrophage proliferation, and plaque destabilization, all of which accelerate atherosclerosis. This evidence concerns the gene AIM2 and atherosclerosis.